Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Total Liabilities (Quarterly) : 1.743B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.743B |
| March 31, 2026 | 1.685B |
| December 31, 2025 | 1.675B |
| September 30, 2025 | 1.645B |
| June 30, 2025 | 2.006B |
| March 31, 2025 | 2.187B |
| December 31, 2024 | 1.876B |
| September 30, 2024 | 1.907B |
| June 30, 2024 | 1.883B |
| March 31, 2024 | 1.833B |
| December 31, 2023 | 1.856B |
| September 30, 2023 | 1.860B |
| June 30, 2023 | 1.832B |
| March 31, 2023 | 1.786B |
| December 31, 2022 | 1.775B |
| September 30, 2022 | 1.738B |
| June 30, 2022 | 1.691B |
| March 31, 2022 | 1.622B |
| December 31, 2021 | 1.492B |
| September 30, 2021 | 1.501B |
| June 30, 2021 | 1.465B |
| March 31, 2021 | 1.255B |
| December 31, 2020 | 1.269B |
| September 30, 2020 | 1.116B |
| June 30, 2020 | 1.063B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.049B |
| December 31, 2019 | 1.067B |
| September 30, 2019 | 1.118B |
| June 30, 2019 | 727.94M |
| March 31, 2019 | 728.98M |
| December 31, 2018 | 716.64M |
| September 30, 2018 | 688.38M |
| June 30, 2018 | 659.71M |
| March 31, 2018 | 659.20M |
| December 31, 2017 | 658.23M |
| September 30, 2017 | 426.09M |
| June 30, 2017 | 394.60M |
| March 31, 2017 | 381.37M |
| December 31, 2016 | 393.50M |
| September 30, 2016 | 388.10M |
| June 30, 2016 | 235.60M |
| March 31, 2016 | 228.38M |
| December 31, 2015 | 241.08M |
| September 30, 2015 | 237.99M |
| June 30, 2015 | 230.14M |
| March 31, 2015 | 224.97M |
| December 31, 2014 | 218.33M |
| September 30, 2014 | 220.86M |
| June 30, 2014 | 247.44M |
| March 31, 2014 | 166.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| DexCom, Inc. | 3.834B |
| Boston Scientific Corp. | 20.04B |
| PROCEPT BioRobotics Corp. | 139.28M |
| Globus Medical, Inc. | 719.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.165B |
| Shareholders Equity (Quarterly) | 1.422B |
| Debt to Equity Ratio | 0.6669 |
| Current Ratio | 2.448 |
| Net Debt Paydown Yield | 1.41% |